Inactivated PCV2 one shot vaccine applied in 3-week-old piglets: Improvement of production parameters and interaction with maternally derived immunity (Q57207354)

From Wikidata

Jump to navigation Jump to search

article

Language	Label	Description	Also known as
English	Inactivated PCV2 one shot vaccine applied in 3-week-old piglets: Improvement of production parameters and interaction with maternally derived immunity	article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22245604%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Inactivated PCV2 one shot vaccine applied in 3-week-old piglets: improvement of production parameters and interaction with maternally derived immunity (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22245604%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22245604%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Llorenç Grau-Roma

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22245604%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22245604%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22245604%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Joaquim Segalés

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22245604%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

author name string

Patxi Sarasola

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22245604%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Nuria Sinovas

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22245604%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Miquel Nofrarías

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22245604%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Rosa López-Jimenez

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22245604%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

language of work or name

0 references

publication date

14 January 2012

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22245604%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22245604%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

30

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22245604%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22245604%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1986-1992

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22245604%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Recent advances in the epidemiology, diagnosis and control of diseases caused by porcine circovirus type 2.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.008

7 January 2021

Porcine circovirus diseases.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.008

7 January 2021

Post-weaning multisystemic wasting syndrome (PMWS) clinical expression under field conditions is modulated by the pig genetic background

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.008

7 January 2021

Porcine circovirus type 2 associated disease: update on current terminology, clinical manifestations, pathogenesis, diagnosis, and intervention strategies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.008

7 January 2021

The effect of vaccination against porcine circovirus type 2 in pigs suffering from porcine respiratory disease complex

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.008

7 January 2021

A field evaluation of mortality rate and growth performance in pigs vaccinated against porcine circovirus type 2

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.008

7 January 2021

Reduction of PMWS-associated clinical signs and co-infections by vaccination against PCV2.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.008

7 January 2021

Porcine circovirus type 2 (PCV2) vaccination of conventional pigs prevents viremia against PCV2 isolates of different genotypes and geographic origins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.008

7 January 2021

A genetically engineered chimeric vaccine against porcine circovirus type 2 (PCV2) improves clinical, pathological and virological outcomes in postweaning multisystemic wasting syndrome affected farms

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.008

7 January 2021

Comparison of the effectiveness of passive (dam) versus active (piglet) immunization against porcine circovirus type 2 (PCV2) and impact of passively derived PCV2 vaccine-induced immunity on vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.008

7 January 2021

Efficacy of different protocols of vaccination against porcine circovirus type 2 (PCV2) in a farm affected by postweaning multisystemic wasting syndrome (PMWS)

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.008

7 January 2021

A chimeric porcine circovirus (PCV) with the immunogenic capsid gene of the pathogenic PCV type 2 (PCV2) cloned into the genomic backbone of the nonpathogenic PCV1 induces protective immunity against PCV2 infection in pigs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.008

7 January 2021

One dose of a porcine circovirus 2 (PCV2) sub-unit vaccine administered to 3-week-old conventional piglets elicits cell-mediated immunity and significantly reduces PCV2 viremia in an experimental model

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.008

7 January 2021

Immune responses and vaccine-induced immunity against Porcine circovirus type 2.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.008

7 January 2021

Mechanisms by which maternal antibodies influence infant vaccine responses: review of hypotheses and definition of main determinants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.008

7 January 2021

High titers of circulating maternal antibodies suppress effector and memory B-cell responses induced by an attenuated rotavirus priming and rotavirus-like particle-immunostimulating complex boosting vaccine regimen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.008

7 January 2021

Development of cell-mediated immunity to porcine circovirus type 2 (PCV2) in caesarean-derived, colostrum-deprived piglets

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.008

7 January 2021

Pathological, Immunohistochemical, and In-situ Hybridization Studies of Natural Cases of Postweaning Multisystemic Wasting Syndrome (PMWS) in Pigs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.008

7 January 2021

Absence of evidence of porcine circovirus infection in piglets with congenital tremors.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.008

7 January 2021

Infection, excretion and seroconversion dynamics of porcine circovirus type 2 (PCV2) in pigs from post-weaning multisystemic wasting syndrome (PMWS) affected farms in Spain and Denmark.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.008

7 January 2021

Comparison of porcine circovirus type 2 load in serum quantified by a real time PCR in postweaning multisystemic wasting syndrome and porcine dermatitis and nephropathy syndrome naturally affected pigs.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.008

7 January 2021

Inter-laboratory and inter-assay comparison on two real-time PCR techniques for quantification of PCV2 nucleic acid extracted from field samples.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.008

7 January 2021

Serum antibodies to porcine circovirus type 1 and type 2 in pigs with and without PMWS

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.008

7 January 2021

Effect of porcine circovirus type 2 (PCV2) vaccination on porcine reproductive and respiratory syndrome virus (PRRSV) and PCV2 coinfection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.008

7 January 2021

Immunity in neonates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.008

7 January 2021

Induction of immune suppression in the chick by an optimal dose of an immunizing antigen in the presence of its specific maternal antibody

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.008

7 January 2021

Influence of maternal antibodies on efficacy of porcine circovirus type 2 (PCV2) vaccination to protect pigs from experimental infection with PCV2.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.008

7 January 2021

Immunity conferred by an experimental vaccine based on the recombinant PCV2 Cap protein expressed in Trichoplusia ni-larvae.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.008

7 January 2021

Identifiers

10.1016/J.VACCINE.2012.01.008

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22245604%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22245604%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q57207354&oldid=1953396676"